PRODUCT COMPRISING HYDROLIZED COLLAGEN AND AT LEAST ONE AMORPHOUS MICRONIZED DRUG, PROCESS FOR THE PREPARATION THEREOF AND RELATED USES IN MEDICAL FIELD
The present invention relates to a product consisting of a conglomerate of collagen, in the form of the partly hydroyzed industrial derivative thereof called gelatine, and an amorphous micronized drug, characterized by a high bioavailability of the micronized active ingredient and a safety of use of the same deriving from the protective action of collagen against the harmful effects of contact with the active ingredient.
